News & Articles

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development

Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency

Increasing Portuguese market presence by enhancing sales and after-sales support networks

RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein

Watch our curated collection of The Scientists' Channel interviews from some of the experts joining us at this year's summit

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella

Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development

The SARS-CoV-2 Rapid Antigen Test Nasal uses a nasal swab to quickly and conveniently collect specimens from people suspected of having an active infection

Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar

The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

RNA controls can help avoid false negative results

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination